Fungi Bioactive Metabolites: Integration of Pharmaceutical Applications
暫譯: 真菌生物活性代謝物：藥物應用的整合

Dr. Sunil Kumar Deshmukh is Scientific Advisor to Greenvention Biotech, Uruli-Kanchan, Pune, India, and Agpharm Bioinnovations LLP, Patiala, Punjab, India. Veteran industrial mycologist spent a substantial part of his career in drug discovery at Hoechst Marion Roussel Limited (now Sanofi India Ltd.), Mumbai, and Piramal Enterprises Limited, Mumbai. He has also served TERI-Deaken Nano Biotechnology Centre, TERI, New Delhi, and as an adjunct associate professor at Deakin University, Australia. He has to his credit 8 patents, 150 publications, and 20 books on various aspects of fungi and natural products of microbial origin. He is a president of the Association of Fungal Biologists (AFB) and a past president of the Mycological Society of India (MSI). He is a fellow of Mycological Society of India, the Association of Biotechnology and Pharmacy, the Society for Applied Biotechnology, and Maharashtra Academy of Science. Dr. Deshmukh serves as a referee for more than 20 national andinternational journals. He has approximately four decades of research experience in getting bioactive from fungi and keratinophilic fungi.

Dr. Jacqueline Aparecida Takahashi is a full professor at the Universidade Federal de Minas Gerais (Brazil). For more than two decades, she has been studying routes to modulate fungal secondary metabolism, and she has been dedicated in recent years to issues related to access to Brazilian biodiversity, in reference to international treaties. She is a member of the Disciplinary Nucleus of Bioactive Natural Products of the Montevideo Group Universities Association (AUGM). She has to her credit 8 patents, 183 publications, and 12 book chapters on natural products from plants and fungi. She is a member of the Brazilian Society of Chemistry (SBQ) and of the Brazilian Society for the Progress of Science (SBPS). She serves as a referee for more than 20 national and international journals.

Dr. Sanjai Saxena currently an academic and researcher with over two decades of experience in bio-tech research and development He is currently a full professor in the Department of Biotechnology, Thapar Institute of Engineering and Technology (Patiala), India. He has embarked upon his journey as an innovator turned entrepreneur and founded a startup, Agpharm Bioinnovations LLP with a pursuit to address the ever-arising unanswered pharmaceutical and agricultural sector needs. He continually focuses on exploring and exploiting novel biomolecules drawn from biological systems and their interactions in nature, particularly plant-microbe interactions. Prof. Saxena, focuses his research primarily on microbial secondary metabolites, microbial diversity and bioprospecting, biochemistry, and drug discovery. His research work has resulted in significant extramural funding, 4 patents, over 78 peer-reviewed publications in referred research journals, 12 book chapters, and 1 book on applied microbiology to his credit. Dr. Saxena is a fellow of Association of Advancement of Biodiversity Science, Karnataka. Prof. Saxena serves as a referee for approximately 25 peer-reviewed journals apart from being on editorial board of a couple of them.

Dr. Sunil Kumar Deshmukh 是印度浦那的 Greenvention Biotech 和旁遮普的 Agpharm Bioinnovations LLP 的科學顧問。這位資深的工業真菌學家在 Hoechst Marion Roussel Limited（現為 Sanofi India Ltd.）和 Piramal Enterprises Limited 的藥物發現領域中度過了他職業生涯的相當一部分。他還曾在新德里的 TERI-Deaken 奈米生物技術中心任職，並擔任澳大利亞迪肯大學的兼任副教授。他擁有 8 項專利、150 篇出版物和 20 本有關真菌及微生物來源天然產品的書籍。他是真菌生物學協會（AFB）的會長，並曾擔任印度真菌學會（MSI）的會長。他是印度真菌學會、農業生物技術與藥學協會、應用生物技術學會和馬哈拉施特拉科學學院的院士。Dr. Deshmukh 擔任超過 20 本國內外期刊的審稿人。他在從真菌和角蛋白親和真菌中獲取生物活性物質方面擁有約四十年的研究經驗。

Dr. Jacqueline Aparecida Takahashi 是巴西米納斯吉拉斯聯邦大學的正教授。她在過去二十多年中一直研究調節真菌次級代謝的途徑，近年來專注於與巴西生物多樣性相關的問題，並參考國際條約。她是蒙特維多大學集團協會（AUGM）生物活性天然產品學科小組的成員。她擁有 8 項專利、183 篇出版物和 12 篇有關植物和真菌天然產品的書籍章節。她是巴西化學學會（SBQ）和巴西科學進步學會（SBPS）的成員。她擔任超過 20 本國內外期刊的審稿人。

Dr. Sanjai Saxena 目前是一位學者和研究人員，擁有超過二十年的生物技術研究與開發經驗。他目前是印度旁遮普 Thapar 工程技術學院生物技術系的正教授。他開始了作為創新者轉型為企業家的旅程，創立了初創公司 Agpharm Bioinnovations LLP，旨在解決不斷出現的未解決的製藥和農業需求。他持續專注於探索和利用來自生物系統的創新生物分子及其在自然界中的相互作用，特別是植物與微生物的相互作用。Saxena 教授的研究主要集中在微生物次級代謝物、微生物多樣性和生物勘探、生物化學以及藥物發現上。他的研究工作獲得了顯著的外部資金支持，擁有 4 項專利、超過 78 篇經同行評審的研究期刊文章、12 篇書籍章節和 1 本有關應用微生物學的書籍。Dr. Saxena 是卡納塔克州生物多樣性科學促進協會的院士。Saxena 教授擔任約 25 本經同行評審的期刊的審稿人，並在其中幾本期刊的編輯委員會中任職。